EUVIMEDEUVIMED entdecken
Crossref

Prognostic impact of immunophenotypic classification for newly diagnosed NPM1 ‐mutated acute myeloid leukemia

Beatriz Martín-Herreros iD, Lourdes Cordón, Claudia Sargas, Samuel Romero, María Dolores Linares, Pilar Lloret, Irene Navarro-Vicente, Isabel Cano, Evelyn Acuña-Cruz, Laura Torres-Miñana, Rebeca Rodríguez-Veiga, David Martínez-Cuadron und 4 weitere

Cytometry Part B: Clinical Cytometry · 2026

DOI: 10.1002/cyto.b.70016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytometry Part B: Clinical Cytometry, 2026. Verfasst von Beatriz Martín-Herreros und 15 weiteren Autor:innen. Beteiligte Einrichtung: Haematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain. Hauptthemen laut MEDLINE: Immunophenotyping, Leukemia, Myeloid, Acute, Nuclear Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Fundación Científica Asociación Española Contra el Cáncer, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NPM1 mutations are among the most frequent genetic alterations in acute myeloid leukemia (AML) and have been associated with several immunophenotypic features. This study aims to characterize the immunophenotypic profile of this entity at diagnosis using multiparametric flow cytometry and to evaluate the impact of phenotype classifications on prognosis. Immunophenotypic analysis enabled the identification and characterization of various populations previously described in this entity, including immature (CD117 + HLA‐DR + ), neutrophil‐committed (CD117 +/heterogeneous HLA‐DR − ), and monocytic (with variable CD117 expression, HLA‐DR + , and CD64 + ) leukemic cells, which were identified as leukemic expansions, as well as populations presenting immunophenotypic alterations. Cases were distributed in seven immunophenotypic patterns based on R‐classification that considers the presence of the three previously described leukemic cell populations but independently of their proportion and relative distribution. Most of the patients included in this study (30, 33%) exhibited an immature and monocytic leukemic cells population (pattern 4), followed by those patients (16, 18%) with a predominant expansion of immature leukemic cells (pattern 1), and those (16, 18%) characterized by a neutrophil‐committed leukemic population (pattern 2). Less frequent patterns included (11, 12%) neutrophil‐committed and monocytic cells population (pattern 6), (7, 8%) coexistence of the three populations (pattern 7), (6, 7%) immature and neutrophil‐committed leukemic cells population (pattern 5), and (5, 5%) predominant expansion of monocytic leukemic cells population (pattern 3). Our analysis indicated that cases with monocytic leukemic cells population predominance exhibit a trend towards a lower cumulative incidence of relapse compared to other leukemic populations, either as the predominant population or across different immunophenotypic patterns. However, differences did not reach statistical significance. These findings help us to contribute with additional information about the biological and immunophenotypic signature of NPM1‐ AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunophenotypingLeukemia, Myeloid, AcuteNuclear ProteinsHumansNucleophosminFemaleFlow CytometryMutationPrognosisMiddle AgedAdultAgedMaleAdolescentAged, 80 and overYoung AdultNeutrophilsHLA-DR Antigens

Stichwörter der Autor:innen

NPM1acute myeloid leukemiadiagnosisflow cytometryimmunophenotype

Substanzen

NucleophosminNPM1 protein, humanNuclear ProteinsHLA-DR Antigens

Autor:innen und Institutionen

  • Haematology Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
  • Centro de Investigación Biomédica en Red de Cáncer (CIBERONC CB16/12/00284), Instituto de Salud Carlos III, Madrid, Spain.
  • Haematology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

ORCID-Profile: Beatriz Martín-Herreros

Förderung

  • Fundación Científica Asociación Española Contra el Cáncer
  • Instituto de Salud Carlos III

Zitieren

APA

Martín-Herreros, B., Cordón, L., Sargas, C., Romero, S., Linares, M. D., Lloret, P., Navarro-Vicente, I., Cano, I., Acuña-Cruz, E., Torres-Miñana, L., Rodríguez-Veiga, R., Martínez-Cuadron, D., Boluda, B., Barragán, E., Sempere, A., & Montesinos, P. (2026). Prognostic impact of immunophenotypic classification for newly diagnosed NPM1 ‐mutated acute myeloid leukemia. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.70016

Vancouver

Martín-Herreros B, Cordón L, Sargas C, Romero S, Linares MD, Lloret P, et al. Prognostic impact of immunophenotypic classification for newly diagnosed NPM1 ‐mutated acute myeloid leukemia. Cytometry Part B: Clinical Cytometry. 2026. doi:10.1002/cyto.b.70016

BibTeX
@article{MartnHerreros2026,
  author = {Martín-Herreros, Beatriz and Cordón, Lourdes and Sargas, Claudia and Romero, Samuel and Linares, María Dolores and Lloret, Pilar and Navarro-Vicente, Irene and Cano, Isabel and Acuña-Cruz, Evelyn and Torres-Miñana, Laura and Rodríguez-Veiga, Rebeca and Martínez-Cuadron, David and Boluda, Blanca and Barragán, Eva and Sempere, Amparo and Montesinos, Pau},
  title = {Prognostic impact of immunophenotypic classification for newly diagnosed NPM1 ‐mutated acute myeloid leukemia},
  journal = {Cytometry Part B: Clinical Cytometry},
  year = {2026},
  doi = {10.1002/cyto.b.70016}
}
Kostenlos starten →